 |
- Last updated refers to the date when our listing for each treatment was last updated.
- ID is our internal ID - starting with VT.
- Min Karnofsky is a general guide to how well you have to function to use this treatment
- For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.
 |
 |
 |
 |
 |
 |
Treatment Name: |
 |
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer |
 |
 |
 |
 |
 |
 |
Keywords: |
 |
Monoclonal Antibody |
 |
 |
 |
 |
Phase: |
 |
Phase 1 |
 |
 |
 |
 |
 |
 |
Treatment ID#s: |
 |
VT1601
NCT00089245
|
 |
 |
 |
 |
Age Group: |
 |
Adult And Pediatric |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
Not Specified |
 |
 |
 |
 |
Conditions: |
 |
Newly Diagnosed: N
Recurrent: Y
Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed Histologically confirmed CNS or leptomeningeal cancer, meeting 1 of the following criteria:
Refractory to conventional therapy OR for which no conventional therapy exists
Less than 10% chance of cure with conventional therapy
Recurrent brain tumor or other solid tumor with a predilection for leptomeningeal dissemination, including, but not limited to, the following:
Medulloblastoma
Ewing`s sarcoma/primitive neuroectodermal tumor
Rhabdoid tumor
Neuroblastoma
Osteosarcoma
Desmoplastic small rounded-cell tumor
Rhabdomyosarcoma
8H9 reactivity confirmed by immunohistochemical staining
|
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
11/27/2005 |
 |
 |
 |
 |
Tumor Types: |
 |
Any Malignant Brain Tumor Medulloblastoma Recurrent Malignant Pediatric Brain Tumors |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
|
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Immunological, Biological or Targeted Therapy. |
 |
 |
 |
 |
Contact: |
 |
Memorial Sloan-Kettering Cancer Center Kim Kramer, MD New York, NY 10021 Phone: 212-639-6410 Click here to send an email |
 |
 |
|
|